Sequoia Financial Advisors LLC Acquires Stake in Nutrien Ltd.
Sequoia Financial Advisors LLC has recently reported a new investment in Nutrien Ltd. (NYSE:NTR) during the fourth quarter, as detailed in their latest filing with the Securities and Exchange Commission. The firm has acquired a total of 5,588 shares of Nutrien's stock, amounting to an approximate value of $250,000.
Changes in Institutional Holdings
In addition to Sequoia Financial, several other hedge funds and institutional investors have also adjusted their positions in Nutrien. For example, Goodman Financial Corp increased its shareholding by 4.6% in the third quarter, owning now 253,860 shares valued at $12,201,000 after purchasing an additional 11,058 shares. Likewise, Charles Schwab Investment Management Inc. raised its stake by 10.0%, bringing its total to 1,742,351 shares worth $83,812,000 after acquiring an extra 157,932 shares.
Furthermore, Covea Finance increased its stake by 21.9% in the fourth quarter, now retaining 55,600 shares valued at $2,485,000 following a purchase of 10,000 shares. Clal Insurance Enterprises Holdings Ltd. significantly boosted its holdings by 78.8%, moving to own 2,495,282 shares valued at $121,271,000 after acquiring an impressive 1,100,000 additional shares. Finally, Wellington Management Group LLP increased its stake by 12.2%, resulting in ownership of 1,396,887 shares valued at $67,200,000 due to an additional purchase of 151,596 shares.
Currently, hedge funds and other institutional investors hold around 63.10% of Nutrien's stock.
Analysts’ Perspectives on Nutrien
Recent analysis from various financial institutions has led to adjusted targets for Nutrien. Scotiabank raised their price target from $60.00 to $62.00 and endorsed a "sector outperform" rating. Oppenheimer commenced coverage with an "outperform" rating and a $60.00 price target. UBS Group increased their target from $53.00 to $54.00 with a "neutral" rating, while the Royal Bank of Canada also maintained an "outperform" rating with a target of $60.00. CIBC further elevated their target price from $64.00 to $66.00, keeping an "outperformer" rating on Nutrien. The consensus rating for Nutrien stands at "Hold" with a target price averaging $60.13, amongst ratings from various analysts, including sell, hold, and buy ratings.
Stock Performance Overview
As of Thursday, Nutrien (NYSE:NTR) started trading at $52.35. Over the past year, the stock has seen a low of $43.70 and a high of $60.87. Nutrien has a market capitalization of $25.61 billion, a price-to-earnings ratio of 38.21, a price-to-earnings-growth ratio of 1.19, and a beta of 0.81. Moving averages indicate a fifty-day average of $51.50 and a 200-day average of $48.76. Nutrien’s financial health reflects a quick ratio of 0.82, a current ratio of 1.27, and a debt-to-equity ratio of 0.38.
Recent Earnings and Dividend Announcements
Nutrien recently released its earnings report, revealing an earnings per share (EPS) of $0.28, which fell short of the consensus estimate of $0.37. The reported revenue for the quarter was $5.08 billion, close to analyst expectations of $5.09 billion. The company reported a net margin of 2.62% and a return on equity of 6.81%. Analysts project Nutrien will achieve an EPS of 3.72 for the current fiscal year.
Additionally, Nutrien has announced a quarterly dividend of $0.545, expected to be paid to investors on April 10th, with the record date on March 31st. This dividend represents an annual payment of $2.18, resulting in a yield of 4.16%, although the payout ratio currently stands at 159.12%.
Nutrien's Business Segments
Nutrien Ltd. operates in the agricultural sector, providing crop inputs and services across four main segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment is responsible for the distribution of crop nutrients, crop protection products, seeds, and merchandise. The Potash segment specializes in both granular and standard potash products.
This report was generated with the assistance of financial data and tools to ensure accuracy and timely reporting.
Investment, Shares, Growth